Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $374,477 - $616,457
3,700 New
3,700 $439,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $834,120 - $1.25 Million
-12,000 Reduced 46.33%
13,900 $1.38 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $993,023 - $1.3 Million
-10,300 Reduced 28.45%
25,900 $2.68 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $1.88 Million - $2.55 Million
15,900 Added 78.33%
36,200 $4.4 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $2.75 Million - $4 Million
20,300 New
20,300 $3.12 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $2.83 Million - $4.66 Million
24,000 New
24,000 $2.84 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.